全文获取类型
收费全文 | 1628篇 |
免费 | 77篇 |
国内免费 | 14篇 |
专业分类
耳鼻咽喉 | 5篇 |
儿科学 | 29篇 |
妇产科学 | 61篇 |
基础医学 | 158篇 |
口腔科学 | 37篇 |
临床医学 | 199篇 |
内科学 | 314篇 |
皮肤病学 | 26篇 |
神经病学 | 154篇 |
特种医学 | 147篇 |
外科学 | 242篇 |
综合类 | 22篇 |
预防医学 | 97篇 |
眼科学 | 3篇 |
药学 | 162篇 |
中国医学 | 4篇 |
肿瘤学 | 59篇 |
出版年
2022年 | 11篇 |
2021年 | 18篇 |
2020年 | 16篇 |
2019年 | 20篇 |
2018年 | 18篇 |
2017年 | 11篇 |
2016年 | 29篇 |
2015年 | 25篇 |
2014年 | 29篇 |
2013年 | 58篇 |
2012年 | 57篇 |
2011年 | 56篇 |
2010年 | 49篇 |
2009年 | 64篇 |
2008年 | 62篇 |
2007年 | 76篇 |
2006年 | 56篇 |
2005年 | 53篇 |
2004年 | 61篇 |
2003年 | 65篇 |
2002年 | 52篇 |
2001年 | 50篇 |
2000年 | 62篇 |
1999年 | 53篇 |
1998年 | 51篇 |
1997年 | 49篇 |
1996年 | 41篇 |
1995年 | 40篇 |
1994年 | 28篇 |
1993年 | 34篇 |
1992年 | 40篇 |
1991年 | 23篇 |
1990年 | 37篇 |
1989年 | 34篇 |
1988年 | 49篇 |
1987年 | 49篇 |
1986年 | 26篇 |
1985年 | 23篇 |
1984年 | 15篇 |
1983年 | 20篇 |
1982年 | 12篇 |
1981年 | 8篇 |
1980年 | 6篇 |
1979年 | 12篇 |
1978年 | 8篇 |
1977年 | 11篇 |
1976年 | 10篇 |
1974年 | 5篇 |
1973年 | 7篇 |
1971年 | 5篇 |
排序方式: 共有1719条查询结果,搜索用时 15 毫秒
61.
62.
Background BRCA1 and BRCA2 pathogenic variants (PVs) are associated with prostate cancer (PCa) risk, but a wide range of relative risks (RRs) has been reported.Methods We systematically searched PubMed, Embase, MEDLINE and Cochrane Library in June 2021 for studies that estimated PCa RRs for male BRCA1/2 carriers, with no time or language restrictions. The literature search identified 27 studies (BRCA1: n = 20, BRCA2: n = 21).Results The heterogeneity between the published estimates was high (BRCA1: I2 = 30%, BRCA2: I2 = 83%); this could partly be explained by selection for age, family history or aggressive disease, and study-level differences in ethnicity composition, use of historical controls, and location of PVs within BRCA2. The pooled RRs were 2.08 (95% CI 1.38–3.12) for Ashkenazi Jewish BRCA2 carriers, 4.35 (95% CI 3.50–5.41) for non-Ashkenazi European ancestry BRCA2 carriers, and 1.18 (95% CI 0.95–1.47) for BRCA1 carriers. At ages <65 years, the RRs were 7.14 (95% CI 5.33–9.56) for non-Ashkenazi European ancestry BRCA2 and 1.78 (95% CI 1.09–2.91) for BRCA1 carriers.Conclusions These PCa risk estimates will assist in guiding clinical management. The study-level subgroup analyses indicate that risks may be modified by age and ethnicity, and for BRCA2 carriers by PV location within the gene, which may guide future risk-estimation studies.Subject terms: Cancer epidemiology, Cancer epigenetics, Prostate cancer, Risk factors 相似文献
63.
64.
65.
66.
67.
68.
69.
Bukowski R Uchida T Smith GC Malone FD Ball RH Nyberg DA Comstock CH Hankins GD Berkowitz RL Gross SJ Dugoff L Craigo SD Timor IE Carr SR Wolfe HM D'Alton ME;First Second Trimester Evaluation of Risk 《Obstetrics and gynecology》2008,111(5):1065-1076
OBJECTIVE: To demonstrate that individualized optimal fetal growth norms, accounting for physiologic and pathologic determinants of fetal growth, better identify normal and abnormal outcomes of pregnancy than existing methods. METHODS: In a prospective cohort of 38,033 singleton pregnancies, we identified 9,818 women with a completely normal outcome of pregnancy and characterized the physiologic factors affecting birth weight using multivariable regression. We used those physiologic factors to individually predict optimal growth trajectory and its variation, growth potential, for each fetus in the entire cohort. By comparing actual birth weight with growth potential, population, ultrasound, and customized norms, we calculated for each fetus achieved percentiles, by each norm. We then compared proportions of pregnancies classified as normally grown, between 10th and 90th percentile, or aberrantly grown, outside this interval, by growth potential and traditional norms, in 14,229 complicated pregnancies, 1,518 pregnancies with diabetes or hypertensive disorders, and 1,347 pregnancies with neonatal complications. RESULTS: Nineteen physiologic factors, associated with maternal characteristics and early placental function, were identified. Growth potential norms correctly classified significantly more pregnancies than population, ultrasound, or customized norms in complicated pregnancies (26.4% compared with 18.3%, 18.7%, 22.8%, respectively, all P<.05), pregnancies with diabetes or hypertensive disorders (37.3% compared with 23.0%, 28.0%, 34.0%, respectively, all P<.05) and neonatal complications (33.3% compared with 19.7%, 24.9%, 29.8%, respectively, all P<.05). CONCLUSION: Growth potential norms based on the physiologic determinants of birth weight are a better discriminator of aberrations of fetal growth than traditional norms. LEVEL OF EVIDENCE: II. 相似文献
70.
Justin W. Collins Stavros Tyritzis Tommy Nyberg Martin SchumacherOscar Laurin Dinyar KhazaeliChristofer Adding Martin N. JonssonAbolfazl Hosseini N. Peter Wiklund 《European urology》2013